Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Astrazeneca : Vaccination Against Covid-19 Resumes Sept 24

09/23/2021 | 11:06am EDT

The Ghana Health Service (GHS) will from tomorrow, Friday, September 24, 2021, resume the administration of AstraZeneca, COVID-19 vaccines to eligible persons.

The Greater Accra Regional Director of Health, Dr Charity Sarpong, who made the disclosure to the Ghanaian Times, yesterday, said the exercise which will end on Wednesday, September 29, 2020, would cover all 29 districts of the region.

She said, persons 18 years and above awaiting the second dose of vaccination as well as those who have never had a shot of any COVID-19 vaccine, were targeted under the exercise.

"We have received about 182,187 doses of AstraZeneca vaccines to administer in this one-week exercise and looking at the level of positive response we have received since we began vaccination, we hope to exhaust this sooner than anticipated," Dr Sarpong said.

Explaining why the GHS was yet to administer Moderna vaccines, recently received by authorities in the country, Dr Sarpong said administrative processes on deployment was being finalised to allow for its use under the COVID-19 inoculation programme.

"For now, it is AstraZeneca we are administering and once we receive the green light to use Moderna, we will continue with it," she said.

Dr Sarpong urged members of the public to visit the nearest vaccination centre with national identification card in the case of first timers, and the COVID-19 vaccination card for persons due for second dose, to receive their jabs.

"This time, there are no restrictions, all persons, provided you are 18 years and above, can walk to any vaccination centre and be vaccinated. Remember, the disease is still around and vaccines are safe to protect us against infection and serious illnesses from COVID-19. We still encourage that people keep to the protocol and wear their masks even after vaccination," she advised.

Meanwhile, Ghana is still recording new cases of COVID-19 although, at marginal rates.

Latest update from the GHS indicates that 265 new cases were recorded as of September 17, 2021, from six out of the country's 16 regions and the Kotoka International Airport (KIA).

Majority of the new infections were: the Greater Accra region, 195, followed by Central Region, 30; Western, 13; Ashanti, 11; Eastern, three, and one case from the Bono Region.

Twelve of the new infections were recorded at the KIA.

So far, Ghana has secured over 3.2 million vaccines for its COVID-19 vaccine deployment programme.

Despite initial challenges in vaccine acquisition, which stalled vaccination, government said it remained on course to achieve at least 60 per cent herd exercise by vaccinating 20 million Ghanaians by the end of 2021.

Copyright Ghanaian Times. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.32% 8985 Delayed Quote.22.09%
MODERNA, INC. 7.05% 349.56 Delayed Quote.234.60%
All news about ASTRAZENECA PLC
02:58aVACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
RE
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
MT
10/25WALL STREET STOCK EXCHANGE : 84% of Q3 earnings reports exceed expectations
10/25ANALYST RECOMMENDATIONS : American Express, Beyond Meat, Microsoft, Oracle, Weibo...
10/25UNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
AQ
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
AQ
10/25ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
PU
10/25ASTRAZENECA : S.Korea to donate 1 mln doses of AstraZeneca's vaccine to Iran -KDCA
RE
10/25Medivir Appoints Jens Lindberg as Chief Executive Officer
AQ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 715 M - -
P/E ratio 2021 35,6x
Yield 2021 2,29%
Capitalization 191 B 191 B -
EV / Sales 2021 6,08x
EV / Sales 2022 4,92x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 123,07 $
Average target price 137,82 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.09%190 828
JOHNSON & JOHNSON4.26%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.25%241 929
ELI LILLY AND COMPANY45.14%222 158